医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

遺伝学

HitGen and Morphic Extend Drug Discovery Research Collaboration

HitGen and Morphic Extend Drug Discovery Research Collaboration

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: HitGen and Morphic Extend Drug Discovery Research Collaboration

2020年07月06日

AVROBIO Announces the Appointment of Kim Raineri as Chief Manufacturing and Technology Officer

AVROBIO Announces the Appointment of Kim Raineri as Chief Manufacturing and Technology Officer

その他ヘルスバイオテクノロジーヘルスケア医療機器幹細胞遺伝学　 TimeLine: AVROBIO Announces the Appointment of Kim Raineri as Chief Manufacturing and Technology Officer

2020年06月29日

Sengenics Launches ImmuSAFE COVID+, the World’s First High-Throughput, Multi-Antigen COVID-19 Biochip Test

Sengenics Launches ImmuSAFE COVID+, the World’s First High-Throughput, Multi-Antigen COVID-19 Biochip Test

その他ヘルスバイオテクノロジーヘルスケア感染症製薬遺伝学　 TimeLine: Biochip Test Multi-Antigen COVID Sengenics Launches ImmuSAFE COVID+the World’s First High-Throughput

2020年06月23日

Personalis宣布与贝瑞基因建立合作伙伴关系以在中国扩大市场

Personalis宣布与贝瑞基因建立合作伙伴关系以在中国扩大市场

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬遺伝学　 TimeLine: Personalis宣布与贝瑞基因建立合作伙伴关系以在中国扩大市场

2020年06月12日

Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China’s Public Hospitals

Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China’s Public Hospitals

バイオテクノロジーヘルスケア医療機器腫瘍学製薬遺伝学　 TimeLine: Genetron Health Strengthens Partnership with Thermo Fisher Scientific to Expand Precision Cancer Diagnosis and Monitoring Across China’s Public Hospitals

2020年06月11日

Personalis Announces a Partnership with Berry Genomics for China Expansion

Personalis Announces a Partnership with Berry Genomics for China Expansion

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬遺伝学　 TimeLine: Personalis Announces a Partnership with Berry Genomics for China Expansion

2020年06月11日

CANbridge Pharmaceuticals Enters Into Rare Disease Gene Therapy Research Agreement With UMass Medical School

CANbridge Pharmaceuticals Enters Into Rare Disease Gene Therapy Research Agreement With UMass Medical School

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: CANbridge Pharmaceuticals Enters Into Rare Disease Gene Therapy Research Agreement With UMass Medical School

2020年06月09日

Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked & Available in Europe

Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked & Available in Europe

バイオテクノロジーヘルスケアヘルス一般腫瘍学製薬遺伝学　 TimeLine: Analysis System CE Marked MSI Dx OncoMate Promega Microsatellite Instability Molecular Test

2020年06月09日

HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration

HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration

バイオテクノロジーヘルスケア製薬遺伝学　 TimeLine: HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration

2020年06月08日

New Data from the Phase 3 HELP Study Open-Label Extension Evaluate the Long-Term Safety and Efficacy of TAKHZYRO® (lanadelumab) in Reducing Hereditary Angioedema Attacks

New Data from the Phase 3 HELP Study Open-Label Extension Evaluate the Long-Term Safety and Efficacy of TAKHZYRO® (lanadelumab) in Reducing Hereditary Angioedema Attacks

バイオテクノロジーヘルスケア臨床試験製薬遺伝学　 TimeLine: Evaluate the Long-Term Safety and Efficacy of TAKHZYRO HELP Study Open-Label Extension Hereditary Angioedema Attacks in Reducing lanadelumab

2020年06月06日